CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-28 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-01-28 | Schwartz Jonathan David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-01-28 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-01-28 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-01-28 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-01-28 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +4,666 | $9.96 | $46K | 4,666 |
| 2019-01-28 | Militello John | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-28 | Yalamanchi Naveen Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-01-28 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +40,500 | 40,500 | ||
| 2019-01-28 | Shah Gaurav Director | Grant or award · Stock Option (Right to Buy) | +315,700 | 315,700 | ||
| 2019-01-28 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2018-12-28 | WONG RODERICK Director | Grant or award | +100,000 | $13.93 | $1.4M | 16,507,319 |
| 2018-12-20 | Patel Kinnari Chief Operating Officer | Exercise or conversion | +55,869 | $1.21 | $68K | 55,869 |
| 2018-12-20 | Patel Kinnari Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | +55,869 | 111,738 | ||
| 2018-12-13 | SOUTHWELL DAVID P Director | Sale | −38,768 | $15.19 | $589K | 95,160 |
| 2018-12-07 | SOUTHWELL DAVID P Director | Sale | −4,923 | $14.91 | $73K | 133,928 |
| 2018-12-06 | SOUTHWELL DAVID P Director | Sale | −52,809 | $15.15 | $800K | 138,851 |
| 2018-12-06 | Patel Kinnari Chief Operating Officer | Purchase | +5,675 | $14.98 | $85K | 5,675 |
| 2018-11-28 | SOUTHWELL DAVID P Director | Exercise or conversion | +153,125 | 191,660 | ||
| 2018-11-28 | SOUTHWELL DAVID P Director | Exercise or conversion · Restricted Stock Units | −65,625 | 0 |
Page 26 of 27 · 538 trades